Biotech News
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
investor.aligos.com2026-05-07 20:08 EST
SOUTH SAN FRANCISCO, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today reported recent business progress and